Plus Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Nov 23 | SellUS$4,053 | Marc Hedrick | Individual | 2,068 | US$1.96 | |
16 Nov 23 | BuyUS$3,720 | Robert Lenk | Individual | 2,000 | US$1.95 | |
13 Nov 23 | BuyUS$8,620 | Robert Lenk | Individual | 6,000 | US$1.45 | |
09 Nov 23 | BuyUS$14,926 | Robert Lenk | Individual | 9,199 | US$1.65 | |
07 Nov 23 | BuyUS$11,933 | Robert Lenk | Individual | 7,395 | US$1.64 | |
13 Sep 23 | BuyUS$10,022 | Howard Clowes | Individual | 6,993 | US$1.43 | |
11 Sep 23 | BuyUS$34,062 | Gregory Petersen | Individual | 20,000 | US$1.70 | |
06 Jun 23 | BuyUS$3,980 | Howard Clowes | Individual | 1,000 | US$3.98 | |
03 May 23 | BuyUS$9,102 | Howard Clowes | Individual | 2,500 | US$3.64 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 572 | 0.0134% |
Individual Insiders | 62,005 | 1.45% |
Institutions | 139,353 | 3.26% |
General Public | 4,074,152 | 95.3% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 71.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
33,000 | US$57.4k | 0% | no data | |||
32,541 | US$56.6k | 101% | no data | |||
26,543 | US$46.2k | 0% | no data | |||
25,160 | US$43.8k | 4,340% | no data | |||
24,166 | US$42.1k | 0% | no data | |||
16,839 | US$29.3k | 0% | no data | |||
14,303 | US$24.9k | 0% | 0.09% | |||
11,693 | US$20.4k | 0% | no data | |||
8,899 | US$15.5k | 72.8% | no data | |||
6,960 | US$12.1k | 0% | no data | |||
815 | US$1.4k | 0% | no data | |||
572 | US$995.8 | -60.6% | no data | |||
170 | US$296.2 | -92.4% | no data | |||
133 | US$231.5 | 0% | no data | |||
99 | US$172.7 | 4,850% | no data | |||
35 | US$61.0 | 66.7% | no data | |||
1 | US$1.5 | 0% | no data | |||
1 | US$1.5 | 0% | no data |